HUTCHISON CHINA/S (HCM) Stock Price Down 7%

HUTCHISON CHINA/S (NASDAQ:HCM) traded down 7% during mid-day trading on Tuesday . The company traded as low as $32.66 and last traded at $32.93. 581,694 shares changed hands during trading, a decline of 29% from the average session volume of 818,742 shares. The stock had previously closed at $35.42.

A number of equities research analysts have issued reports on the company. Zacks Investment Research raised HUTCHISON CHINA/S from a “sell” rating to a “hold” rating in a research report on Thursday, November 15th. BidaskClub raised HUTCHISON CHINA/S from a “hold” rating to a “buy” rating in a research report on Thursday, November 1st.

The company has a quick ratio of 4.55, a current ratio of 4.67 and a debt-to-equity ratio of 0.06. The stock has a market cap of $4.58 billion, a PE ratio of -149.68 and a beta of 0.01.

Several institutional investors and hedge funds have recently modified their holdings of the business. Renaissance Technologies LLC lifted its stake in shares of HUTCHISON CHINA/S by 375.0% during the third quarter. Renaissance Technologies LLC now owns 32,300 shares of the company’s stock worth $1,040,000 after purchasing an additional 25,500 shares in the last quarter. Allianz Asset Management GmbH lifted its stake in shares of HUTCHISON CHINA/S by 47.3% during the third quarter. Allianz Asset Management GmbH now owns 447,494 shares of the company’s stock worth $14,405,000 after purchasing an additional 143,765 shares in the last quarter. Bellevue Group AG lifted its stake in shares of HUTCHISON CHINA/S by 20.3% during the third quarter. Bellevue Group AG now owns 400,029 shares of the company’s stock worth $12,877,000 after purchasing an additional 67,493 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of HUTCHISON CHINA/S by 9.9% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 133,479 shares of the company’s stock worth $4,297,000 after purchasing an additional 12,049 shares in the last quarter. Finally, Alps Advisors Inc. lifted its stake in shares of HUTCHISON CHINA/S by 22.5% during the third quarter. Alps Advisors Inc. now owns 235,130 shares of the company’s stock worth $7,569,000 after purchasing an additional 43,197 shares in the last quarter. Institutional investors own 11.79% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/12/05/hutchison-china-s-hcm-stock-price-down-7.html.

About HUTCHISON CHINA/S (NASDAQ:HCM)

Hutchison China MediTech Limited, a biopharmaceutical company, engages in the research, development, manufacture, and sale of pharmaceuticals and healthcare products primarily in the People's Republic of China and Hong Kong. It operates through Innovation Platform and Commercial Platform segments.

Featured Article: What is an SEC Filing?

Receive News & Ratings for HUTCHISON CHINA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHISON CHINA/S and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply